Donna Pratiwi
Ngoerah Hospital/Faculty of Medicine, Udayana University, Denpasar, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Prognostic performance of GNRI versus PNI for predicting mortality in elderly critically ill patients : A Systematic Review and Meta-Analysis Donna Pratiwi; Agustinus I Wayan Harimawan
World Nutrition Journal Vol. 9 No. 2 (2026): WNJ. Volume 09 Issue 2, February 2026
Publisher : Indonesian Nutrition Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25220/WNJ.V09.i2.0001

Abstract

Background: Malnutrition significantly impacts outcomes in elderly critically ill patients. The Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) are two established tools to assess nutritional status and predict mortality. However, their comparative prognostic performance in this population remains unclear. Objective: This study aimed to compare the predictive ability of GNRI and PNI for mortality among elderly ICU patients. Methods: We conducted a systematic search in PubMed, Scopus, and Web of Science for studies assessing GNRI and/or PNI in relation to mortality in ICU patients aged ≥60 years. We extracted mean and standard deviation values for survivors and non-survivors. Meta-analyses were conducted to calculate pooled mean differences (MD) with 95% confidence intervals (CI), and heterogeneity was evaluated using the I² statistic. Results: Eight studies involving 6,217 ICU patients were included. Both GNRI and PNI scores were significantly lower in non-survivors. The pooled MD for GNRI was −8.99 [95% CI −9.71 to −8.27] (I² = 86%), and for PNI was −4.45 [95% CI −4.94 to −3.96] (I² = 47%). GNRI showed a larger effect size but greater heterogeneity, while PNI results were more consistent. Most studies had low to moderate risk of bias based on the ROBINS-E tool. Conclusion: GNRI and PNI are valid prognostic tools for predicting mortality in elderly ICU patients. GNRI may provide stronger predictive value, whereas PNI offers more consistent prognostic performance.
Effect of vitamin D supplementation regimens on clinical outcomes in asthma: A systematic review Donna Pratiwi; Ni Ketut Sumartini; I Wayan Weta; Agustinus I Wayan Harimawan
World Nutrition Journal Vol. 10 No. 1 (2026): WNJ. Volume 10 Issue 1, Agustus 2026
Publisher : Indonesian Nutrition Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25220/WNJ.V010.i1.0004

Abstract

Background: Vitamin D has immunomodulatory properties that may improve asthma outcomes; however, randomized controlled trials (RCTs) have reported inconsistent findings. Variations in supplementation regimens, particularly bolus versus non-bolus dosing, may contribute to these discrepancies. Objective: To systematically evaluate the effects of vitamin D supplementation on clinical outcomes in patients with asthma, with particular emphasis on dosing regimens. Methods: A systematic review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420261378116). PubMed, Scopus, and the Cochrane Library were searched for RCTs investigating vitamin D supplementation in asthma. Studies were categorized into non-bolus (daily or weekly) and bolus (high-dose intermittent) regimens. Primary outcomes included asthma exacerbations, lung function, and asthma control. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Results: Six RCTs met the inclusion criteria. Non-bolus supplementation was more consistently associated with improved asthma control and modest improvements in lung function, whereas bolus regimens generally showed no significant clinical benefit. Limited benefits of bolus dosing were observed only among participants with severe vitamin D deficiency. Overall, the included studies demonstrated low risk of bias to some concerns. Conclusions: Vitamin D supplementation may improve asthma outcomes, but its effectiveness appears to depend on the dosing regimen. Regular non-bolus supplementation may provide greater clinical benefits than intermittent bolus dosing, particularly in individuals with vitamin D deficiency. Further high-quality RCTs are needed to confirm regimen-specific effects.